Top Markets
#1 ADO Protocol ADO Protocol +194.18%
#2 Islamic Coin Islamic Coin +155.39%
#3 GoPlus Security GoPlus Security +39.78%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 SkyAI SkyAI +14.37%
#7 TENDIES TENDIES +13.92%
#8 Tutorial Tutorial +13.78%
#9 Verus Coin Verus Coin +13.66%
#10 Pons Pons +12.05%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Feng Chi Biotech Corp. Feng Chi Biotech Corp.

Feng Chi Biotech Corp.

6744
Rank in Stocks #33809
Feng Chi Biotech Corp., a company based in Taipei, Taiwan, specializes in... Feng Chi Biotech Corp., a company based in Taipei, Taiwan, specializes in offering a diverse range of diagnostic and scientific services. Their core activities encompass genetic screening for both pre-implantation and prenatal stages, comprehensive life science support, and early detection screening for newborns. Additionally, they perform microbiological assessments for the food and pharmaceutical sectors, alongside engaging in medical translational research. The company also acts as a supplier for various genetic testing technologies and products specifically tailored for the field of oncology.
Share Price
$0.44518639
Market Cap
$6.86M
Change (1 day)
-4.76%
Change (1 year)
-25.72%
Country
TW
Trade Feng Chi Biotech Corp. (6744)

Category

Healthcare
P/E ratio for Feng Chi Biotech Corp. (6744)
P/E ratio as of 2026 TTM: 0
According to Feng Chi Biotech Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Feng Chi Biotech Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 18.38 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.